中国医学科学院肿瘤医院

|专业版大众版English
您所在的位置: >> 科室介绍 >> 病因及癌变研究室>> 发表主要论文 >>正文

发表主要论文

2015年病因及癌变研究室发表论文目录

发布时间:2016-01-29 11:48:17
字号:
+-14
浏览次数:

2015年共发表第一作者或通讯作者研究论文18篇,其中SCI论文13篇,总影响因子约48。另外在国内核心期刊发表通讯作者论文5篇。还发表共同作者SCI论文7篇(总影响因子约50)。

2015年病因及癌变研究室发表论文目录(*通讯作者#并列第一)

2015年发表第一作者或通讯作者文章如下:

1Liu C#, Guo H#, Cheng X, Shao M, Wu C, Wang S, Li H, Wei L, Gao Y, Tan W, Cheng S, Wu T*, Yu D*, Lin D*. Exposure to airborne PM2.5 suppresses microRNA expression and deregulates target oncogenes that cause neoplastic transformation in NIH3T3 cells. Oncotarget. 2015; 6(30):29428-29439.
2Chang J#, Wei L#, Miao X, Yu D, Tan W, Zhang X*, Wu C*, Lin D. Two novel variants on 13q22.1 are associated with risk of esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2015; 24(11):1774-1780.
3Du Z, Zhang W, Zhou Y, Yu D, Chen X, Chang J, Qiao Y, Zhang M, Huang Y, Wu C, Xiao Z*, Tan W*, Lin D. Association of ATM polymorphisms with survival in esophageal squamous cell carcinoma patients receiving radiotherapy. Int J Radiat Oncol Biol Phys. 2015; 93(1):181-189.
4Yu D#, Zhang G#, Huang X, Wu C, Tan W, Qiao Y, Chang J, Zhao H, Bi X, Cai J*, Li Y*, Lin D*. Relatively Small Contribution of Methylation and Genomic Copy Number Aberration to the Aberrant Expression of Inflammation-Related Genes in HBV-Related Hepatocellular Carcinoma. PLoS One. 2015; 10(5):e0126836.
5Yu D, Green B, Marrone A, Guo Y, Kadlubar S, Lin D, Fuscoe J, Pogribny I, Ning B*. Suppression of CYP2C9 by microRNA hsa-miR-128-3p in human liver cells and association with hepatocellular carcinoma. Sci Rep. 2015; 5: 8534.
6An N, Shi X, Zhang Y, Lv N, Feng L, Di X, Han N, Wang G, Cheng S*, Zhang K*. Discovery of a Novel Immune Gene Signature with Profound Prognostic Value in Colorectal Cancer: A Model of Cooperativity Disorientation Created in the Process from Development to Cancer. PLoS One. 2015; 10(9):e0137171.
7Tong R, Feng L, Zhang L, Zhang J, Mao Y, Zhang K, Gao Y, Wang G, Cheng S*. Decreased Interferon Alpha/Beta Signature Associated with Human Lung Tumorigenesis. J Interferon Cytokine Res. 2015; 35(12):963-968.
8An N, Yang X, Cheng S*, Wang G*, Zhang K*. Developmental genes significantly afflicted by aberrant promoter methylation and somatic mutation predict overall survival of late-stage colorectal cancer. Sci Rep. 2015; 5:18616.
9Li F#, Xiao Y#, Huang F#, Deng W#, Zhao H, Shi X, Wang S, Yu X, Zhang L, Han Z, Luo L, Zhu Q, Jiang W, Cheng S*, Li X*, Zhang K*. Spatiotemporal-specific lncRNAs inthe brain, colon, liver and lung of macaque during development. Mol Biosyst. 2015; 11:3253.
10Gu Y, Yang M, Zhao M, Luo Q, Yang L, Peng H, Wang J, Huang S, Zheng Z*, Yuan X*, Liu P*, Huang C*. The de-ubiquitinase UCHL1 promotes gastric cancer metastasis via the Akt and Erk1/2 pathways. Tumor Biol. Published online 28 May 2015; DOI 10.1007/s13277-015-3566-0.
11Yang M, Huang C*. Mitogen-activated protein kinase signaling pathway and invasion and metastasis of gastric cancer. World J Gastroenterol 2015; 21(41): 11673-11679.
12Yang M, Gu Y, Peng H, Zhao M, Wang J, Huang S, Yuan X, Li J, Sang J, Luo Q, Huang C*. NAIF1 inhibits gastric cancer cells migration and invasion via the MAPK pathways. J Cancer Res Clin. 2015; 141(6): 1037-1047.
13Li L, Zhang Y, Li N, Feng L, Yao H, Zhang R, Li B, Li X, Han N, Gao Y, Xiao T*, Wu L*. Nidogen-1: a candidate biomarker for ovarian serous cancer. Jpn J Clin Oncol. 2015; 45(2): 176-182.
14谷愉愉, 赵玫, 杨梅, 王佳, 彭华, 黄声凯, 李佳, 桑建利, 袁兴华, 黄常志*. NAIF1对肝癌细胞HepG2增殖与迁移能力的影响. 现代生物医学进展. 2015; 15(6): 1001-1004.
15彭华, 黄常志*. 代谢组学在肿瘤诊断和治疗中的研究进展. 中华肿瘤杂志. 2015; 37(2): 81-83.
16张萌, 章文成, 杜忠礼, 李洪敏, 黄莹, 于典科, 谭立君, 林东昕, 肖泽芬*, 谭文*. 硫酸类肝素蛋白多糖基因遗传变异与食管鳞癌放疗患者放射性食管炎发生风险的相关性. 中华肿瘤杂志. 2015; 37(6): 422-426.
17阴丽媛, 张文, 肖汀, 荣维淇, 王云, 韩迺珺, 邸雪冰, 郭素萍, 刘滨磊, 张开泰*, 程书钧*. oHSV1-GFP法检测肝癌循环肿瘤细胞.中国组织化学与细胞化学杂志, 2015; 24(3): 203-208.
18曾梓涵, 赵玫, 彭华, 黄声凯, 王佳, 罗清, 冉立, 黄常志*. microRNA-21、microRNAlet-7a在三阴性乳腺癌与Luminal A乳腺癌血清中的表达差异. 实用医学杂志, 2015; 31(21):31-33.